Physician profile
Jeffrey Hurley
NPI 1649379611
$1,973.12
in general payments reported to CMS, 2019-2025
21 companies · $257 in 2025
The $257 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $576 · 2020: $75.18 · 2021: $12.22 · 2022: $123 · 2023: $355 · 2024: $574 · 2025: $257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,178 · Education: $8.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,178.00 |
| Education | $8.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $605.27 | 2019-2025 | Klisyri |
| Abbvie INC. | $419.41 | 2020-2025 | |
| Janssen Biotech, INC. | $300.08 | 2019-2023 | Simponi, Remicade, Stelara |
| Lilly USA, LLC | $126.59 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Ucb, INC. | $103.21 | 2023-2025 | Bimzelx, Cimzia |
| Celgene Corporation | $57.30 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $47.93 | 2023-2024 | Sotyktu |
| Mayne Pharma Commercial LLC | $38.72 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $37.01 | 2024 | Libtayo |
| Galderma Laboratories, L.P. | $36.38 | 2019-2025 | Nemluvio |
| Genentech USA, INC. | $29.93 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $28.54 | 2023 | Ilumya |
| Genzyme Corporation | $25.00 | 2023 | |
| Leo Pharma INC. | $23.55 | 2025 | Anzupgo |
| Dermira, INC. | $19.55 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $15.90 | 2019 | |
| Dermavant Sciences, INC. | $15.03 | 2023 | Vtama |
| Cipher Pharmaceuticals US LLC | $14.52 | 2025 | Natroba, Spinosad |
| Organogenesis INC. | $13.23 | 2023 | Puraply |
| Pfizer INC. | $10.95 | 2019 | |
| Organon LLC | $5.02 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Hurley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.